Trospium Chloride Tablet, Film Coated
Product Images NDC 63629-8457

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 63629-8457). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical structure of trospium chloride showing its molecular framework including a quaternary ammonium ion and chloride counterion, with additional phenyl groups and hydroxyl functionality.*

FDA Label Image

Figure 1 (Image 02)

A pharmacokinetic curve showing plasma concentration (ng/mL) of TROSPIUM CHLORIDE over time (hours post-dose). Data points with error bars indicate measurements from 0 to 48 hours post-oral dose, illustrating the concentration decreasing over time after administration of the 20 mg film-coated tablet.*

FDA Label Image

Figure 2 (Image 03)

A line graph depicting mean change (± standard error) over weeks of treatment in two groups: placebo (N=256) and trosium chloride tablets (N=253). The x-axis represents weeks of treatment (1, 4, and 12), and the y-axis shows mean change values. The graph includes p-value annotations indicating statistical significance between groups at different time points.*

FDA Label Image

Figure 3 (Image 04)

A line graph comparing mean change with standard error (SE) over 1, 4, and 12 weeks of treatment for placebo (N=256) and trospium chloride tablets (N=253). The y-axis represents mean change values, and p-values are displayed for differences between groups at each time point.*

FDA Label Image

Figure 4 (Image 05)

A line graph comparing mean change over weeks of treatment between placebo and Trospium Chloride tablets groups. The x-axis shows weeks of treatment (1, 4, 12), and the y-axis shows mean change with standard error. Trospium Chloride shows a greater decrease than placebo over time, with significance values noted at each time point.*

FDA Label Image

Figure 5 (Image 06)

A line graph depicting mean (±SE) change over weeks of treatment comparing Trospium Chloride tablets and placebo groups. The x-axis represents weeks of treatment (1, 4, 12) and the y-axis shows mean change values. Two lines show a decrease over time for both groups, with Trospium Chloride tablets demonstrating a greater negative mean change compared to placebo. Statistical significance is noted at each time point (p<0.001).*

FDA Label Image

Label (Lbl636298457)

Label for Trospium Chloride Tablets, 20 mg, oral film-coated tablets, by Bryant Ranch Prepack. Features a prominent barcode and text stating the dosage strength. The label includes storage instructions and caution to keep out of children’s reach. Package size is 60 tablets, with BRP Pharmaceuticals logo visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.